Shares of Bath & Body Works, Inc. (NYSE:BBWI – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eighteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. Five analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $45.06.
A number of research analysts recently issued reports on BBWI shares. Telsey Advisory Group restated an “outperform” rating and set a $43.00 price target on shares of Bath & Body Works in a research note on Thursday, February 27th. Citigroup raised Bath & Body Works from a “neutral” rating to a “buy” rating and increased their price objective for the company from $40.00 to $48.00 in a report on Friday, February 28th. Raymond James reaffirmed an “outperform” rating and issued a $46.00 target price (up from $42.00) on shares of Bath & Body Works in a report on Tuesday, February 25th. JPMorgan Chase & Co. set a $47.00 price target on shares of Bath & Body Works in a research note on Thursday, February 27th. Finally, Barclays dropped their price objective on shares of Bath & Body Works from $43.00 to $38.00 and set an “equal weight” rating on the stock in a research note on Monday, March 3rd.
View Our Latest Stock Analysis on Bath & Body Works
Institutional Inflows and Outflows
Bath & Body Works Trading Down 3.0 %
Shares of Bath & Body Works stock opened at $30.93 on Friday. The company has a fifty day simple moving average of $35.21 and a 200-day simple moving average of $34.03. Bath & Body Works has a 12-month low of $26.21 and a 12-month high of $52.99. The stock has a market cap of $6.63 billion, a price-to-earnings ratio of 7.54, a PEG ratio of 0.92 and a beta of 1.89.
Bath & Body Works (NYSE:BBWI – Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.04 by $0.05. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The company had revenue of $2.79 billion during the quarter, compared to the consensus estimate of $2.78 billion. On average, analysts forecast that Bath & Body Works will post 3.3 earnings per share for the current fiscal year.
Bath & Body Works announced that its board has approved a stock repurchase plan on Thursday, February 27th that allows the company to repurchase $500.00 million in shares. This repurchase authorization allows the company to repurchase up to 6.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s board of directors believes its shares are undervalued.
Bath & Body Works Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, March 7th. Shareholders of record on Friday, February 21st were given a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 2.59%. The ex-dividend date of this dividend was Friday, February 21st. Bath & Body Works’s payout ratio is 21.98%.
About Bath & Body Works
Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also
- Five stocks we like better than Bath & Body Works
- What is a Dividend King?
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with MarketBeat.com's FREE daily email newsletter.